Antihyperglycemic effects of M16209, a novel aldose reductase inhibitor, in normal and diabetic rats

By Nakayama K.   Murakami N.   Ohta M.   Kato K.   Ida K.   Mizota M.   Miwa I.   Okuda J.  

European Journal of Pharmacology, Vol. 276, Iss. 1, 1995-03 ,pp. : 77-83

Elsevier

Access to resources Recommend Favorite

The aldose reductase inhibitor sorbinil does not prevent the impairment in nitric oxide-mediated neurotransmission in anococcygeus muscle from diabetic rats

By Way K.J.   Reid J.J.  

European Journal of Pharmacology, Vol. 318, Iss. 1, 1996-12 ,pp. : 101-108

Elsevier

Access to resources Recommend Favorite

Aldose Reductase in Diabetic Microvascular Complications

By  

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 475-486

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of propionyl-l-carnitine on oscillatory potentials in electroretinogram in streptozotocin-diabetic rats

By Hotta N.   Koh N.   Sakakibara F.   Nakamura J.   Hamada Y.   Hara T.   Fukasawa H.   Kakuta H.   Sakamoto N.  

European Journal of Pharmacology, Vol. 311, Iss. 2, 1996-09 ,pp. : 199-206

Elsevier

Access to resources Recommend Favorite

A novel zwitterionic inhibitor of aldose reductase interferes with polyol pathway in ex vivo and in vivo models of diabetic complications

By  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 10, 2014-10 ,pp. : 747-751

Govi-Verlag

Access to resources Recommend Favorite